Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by YukonCorneliuson May 13, 2014 11:36am

179 Views

Post# 22555417

RE:RE:RE:Insider Buying - the first for 2014

Senior Im just trying to encourage a real dialogue here. Many people are under the impression that the companies investors relations isnt doing anything but nothing is further from the truth. The management of the company is doing everything they can to promote SDI, but they are under so many restrictions from the trial and its not going well so they have to be extra careful.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading